We are live on ! Find out more
BCA

Benchmark Capital Advisors Portfolio holdings

AUM $101M
1-Year Est. Return 0.8%
This Fund
S&P 500
This Quarter Est. Return
+9.68%
1 Year Est. Return
-0.8%
3 Year Est. Return
+29.53%
5 Year Est. Return
+43.22%
10 Year Est. Return
–
AUM
$139M
AUM Growth
+$9.62M
Cap. Flow
+$2.42M
Cap. Flow %
1.74%
Top 10 Hldgs %
27.84%
Holding
157
New
14
Increased
39
Reduced
52
Closed
19

Top Buys

Rank Stock Value
1
VOD icon
Vodafone
VOD
+$2.49M
2
BMY icon
Bristol-Myers Squibb
BMY
+$2.34M
3
GM
GEN MOTORS CORP
GM
+$2.05M
4
PCYC
PHARMACYCLICS INC
PCYC
+$1.37M
5
META icon
Meta Platforms (Facebook)
META
+$1.07M

Top Sells

Rank Stock Value
1
LGND icon
Ligand Pharmaceuticals
LGND
+$1.98M
2
HHH icon
Howard Hughes
HHH
+$1.7M
3
DNY
DONNELLEY R R & SONS CO
DNY
+$1.39M
4
NEM icon
Newmont
NEM
+$860K
5
GLW icon
Corning
GLW
+$834K

Sector Composition

Rank Sector Weight
1 Miscellaneous 20.67%
2 Energy 14.21%
3 Technology 10.78%
4 Healthcare 9.81%
5 Consumer Discretionary 9.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
WEN icon
26
Wendy's
WEN
$1.49B
$1.57M 1.12%
184,650
-40,100
-18% -$301K
CHL
27
DELISTED
China Mobile Limited
CHL
$1.55M 1.11%
27,500
+11,150
+68% +$603K
CHSCP
28
CHS Inc 8% Preferred Stock
CHSCP
$327M
$1.53M 1.1%
51,324
– –
ABR icon
29
Arbor Realty Trust
ABR
$938M
$1.51M 1.08%
222,110
+13,700
+7% +$96.9K
CNOB icon
30
Center Bancorp
CNOB
$1.61B
$1.46M 1.05%
102,554
– –
META icon
31
Meta Platforms (Facebook)
META
$1.45T
$1.45M 1.04%
+28,845
New +$1.07M
WPRT
32
Westport Fuel Systems
WPRT
$35.1M
$1.45M 1.04%
5,990
+400
+7% +$117K
MILL
33
DELISTED
MILLER ENERGY RESOURCES, INC COM STK
MILL
$1.37M 0.98%
+188,200
New +$1.05M
MFA
34
MFA Financial
MFA
$896M
$1.28M 0.92%
43,125
+3,975
+10% +$122K
TRIB
35
Trinity Biotech
TRIB
$7.93M
$1.24M 0.89%
380
+36
+10% +$105K
SSW.PRC
36
DELISTED
SEASPAN CORP 9.50% SER C RED PERP PFD SHS (MHL)
SSW.PRC
$1.16M 0.83%
42,618
+1,461
+4% +$39.3K
WU icon
37
Western Union
WU
$2.25B
$1.14M 0.82%
61,300
+8,200
+15% +$147K
PHYS icon
38
Sprott Physical Gold
PHYS
$16.6B
$1.11M 0.8%
100,600
-200
-0.2% -$2.22K
ETN icon
39
Eaton
ETN
$162B
$1.11M 0.8%
16,100
+4,500
+39% +$302K
GS.PRA icon
40
Goldman Sachs Group Inc Depositary Shares
GS.PRA
$575M
$1.11M 0.8%
55,452
– –
F icon
41
Ford
F
$55.6B
$1.1M 0.79%
65,000
+1,700
+3% +$28.7K
SRPT icon
42
Sarepta Therapeutics
SRPT
$2.28B
$1.02M 0.73%
21,650
-400
-2% -$15.4K
MRK icon
43
Merck
MRK
$369B
$981K 0.7%
21,589
-1,257
-6% -$57.4K
DRCO
44
DELISTED
DYNAMICS RESEARCH CORP
DRCO
$972K 0.7%
127,882
+18,412
+17% +$118K
OVV icon
45
Ovintiv
OVV
$18B
$964K 0.69%
11,160
-20
-0.2% -$1.74K
RLH
46
DELISTED
Red Lions Hotel Corporation
RLH
$944K 0.68%
179,137
– –
MNR
47
DELISTED
Monmouth Real Estate Investment Corp
MNR
$936K 0.67%
103,200
+1,000
+1% +$9.48K
O icon
48
Realty Income
O
$58.5B
$894K 0.64%
+23,220
New +$941K
NSC icon
49
Norfolk Southern
NSC
$78.1B
$862K 0.62%
11,150
-500
-4% -$37.5K
KYN icon
50
Kayne Anderson Energy Infrastructure Fund
KYN
$2.5B
$845K 0.61%
23,580
+300
+1% +$10.8K
1
2
3 4 5

Similar funds

OIMU
Orbis Investment Management (US) San Francisco, California $99.7M AUM 17.51% 1-Year Est. Return
7A
734 Agriculture New York $93.8M AUM 0% 1-Year Est. Return
JCP
Jabre Capital Partners Geneva, Switzerland $87.8M AUM 5.24% 1-Year Est. Return
DCM
Diag Capital Management New York $87.4M AUM
BCEM
Bayou City Energy Management Houston, Texas $85.4M AUM
QAM
Questar Asset Management Minneapolis, Minnesota $85M AUM
CFA
Clarfeld Financial Advisors Tarrytown, New York $120M AUM
BPV
Battery Partners VIII Boston, Massachusetts $121M AUM 101.35% 1-Year Est. Return

Benchmark Capital Advisors's Q3 2013 Portfolio in Review

As of Q3 2013, Benchmark Capital Advisors held 157 positions worth $139M, up 7.4% from $130M the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Benchmark Capital Advisors's Q3 2013 filing shows 14 new, 39 increased, 52 reduced and 19 closed positions. Its largest new stake was Bristol-Myers Squibb: 53,400 shares worth $2.47M. The largest sale was Ligand Pharmaceuticals, an estimated $1.98M.

By sector, the portfolio is most concentrated in Miscellaneous at 21% of assets, down from 24% a quarter earlier, followed by Energy and Technology.

  • Benchmark Capital Advisors's largest Q3 2013 buy was Bristol-Myers Squibb: 53,400 shares worth $2.47M.
  • Benchmark Capital Advisors added most to Vodafone in Q3 2013, an estimated $2.49M increase.
  • Benchmark Capital Advisors's biggest Q3 2013 reduction was Howard Hughes, cutting an estimated $1.7M.
  • Benchmark Capital Advisors fully exited Ligand Pharmaceuticals in Q3 2013, selling an estimated $1.98M.
  • Benchmark Capital Advisors's ten largest holdings make up 28% of its $139M portfolio in Q3 2013.
  • Benchmark Capital Advisors opened 14 new positions and closed 19 in Q3 2013.
  • Benchmark Capital Advisors's portfolio value rose 7.4% quarter-over-quarter to $139M.

Based on Benchmark Capital Advisors's 13F filing for Q3 2013, filed 23 Oct 2013.